Difference between revisions of "Hoffmann M, et al, Journal (2020), cited as Ref 39 in DOI: 10.1016/j.clim.2020.108427 (Q11282)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Twelfth Author string (P160): Drosten C, #quickstatements; #temporary_batch_1593104417908)
(‎Created claim: DOI Identifier (P138): 101016/jcell202002052, #quickstatements; #temporary_batch_1593105530610)
 
(2 intermediate revisions by the same user not shown)
Property / Thirteenth Author string
 +
Pohlmann S
Property / Thirteenth Author string: Pohlmann S / rank
 +
Normal rank
Property / title
 +
SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor (English)
Property / title: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor (English) / rank
 +
Normal rank
Property / DOI Identifier
 +
Property / DOI Identifier: 101016/jcell202002052 / rank
 +
Normal rank

Latest revision as of 17:19, 25 June 2020

Cited in: "COVID-19 pathophysiology: A review" Clin Immunol; 2020 Apr 20 108427.
Language Label Description Also known as
English
Hoffmann M, et al, Journal (2020), cited as Ref 39 in DOI: 10.1016/j.clim.2020.108427
Cited in: "COVID-19 pathophysiology: A review" Clin Immunol; 2020 Apr 20 108427.

    Statements

    Journal
    0 references
    2020
    0 references
    Hoffmann M
    0 references
    Kleine-Weber H
    0 references
    Schroeder S
    0 references
    Kruger N
    0 references
    Herrler T
    0 references
    Erichsen S
    0 references
    Schiergens TS
    0 references
    Herrler G
    0 references
    Wu NH
    0 references
    Nitsche A
    0 references
    Muller MA
    0 references
    Drosten C
    0 references
    Pohlmann S
    0 references
    SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor (English)
    0 references